CIK 1834239
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Software & IT Services | 58.77% | 1 |
| Unclassified | 24.85% | 2 |
| Pharmaceuticals & Biotechnology | 16.39% | 2 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | WAY | Waystar Holding Corp. | Information Technology | 58.77% |
| 2 | OCS | OCULIS HOLDING AG | Unclassified | 15.37% |
| 3 | EVMN | Evommune, Inc. | Health Care | 11.10% |
| 4 | PHVS | PHARVARIS N V | Unclassified | 9.48% |
| 5 | AGMB | Agomab Therapeutics NV | Health Care | 5.28% |
3/5 names classified · sector 75.2% of weight · industry 75.2% · mkt cap 69.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 75.2% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 58.8% of book weight (1/5 names) · unclassified 41.2%: OCS, EVMN, PHVS, AGMB. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| WAYWAYSTAR HLDG CORP | — | — | — | 24.9M | 24.9M | 24.9M | $600M |
| OCSOCULIS HOLDING AG | — | — | — | 5.9M | 5.9M | 5.9M | $157M |
| EVMNEVOMMUNE INC | — | — | — | — | 4.9M | 4.9M | $113M |
| PHVSPHARVARIS N V | — | — | — | 3.4M | 3.4M | 3.4M | $97M |
| AGMBAGOMAB THERAPEUTICS NV | — | — | — | — | — | 5.1M | $54M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
